Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: A pilot study

被引:57
作者
Shamloul, R
Ghanem, H
Fahmy, I
El-Meleigy, A
Ashoor, S
Elnashaar, A
Kamel, I
机构
[1] Univ Saskatchewan, Dept Physiol, Saskatoon, SK S7N 5E5, Canada
[2] Cairo Univ, Dept Androl Sexol & STDs, Cairo, Egypt
[3] Erfan Hosp, Dept Androl, Cairo, Egypt
[4] Soliman Fakeeh Hosp, Dept Androl, Cairo, Egypt
关键词
testosterone; sildenafil; PADAM;
D O I
10.1111/j.1743-6109.2005.00071.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Recent studies suggest a direct relationship between free testosterone and cavernous vasodilatation. Some men with erectile dysfunction (ED) associated with PADAM (partial androgen deficiency in aging men) might possibly benefit from testosterone undecanoate therapy (TRT). Objectives. To determine the efficacy of testosterone undecanoate in facilitating the erectile response and patient satisfaction with sildenafil in men 40-70 years old with PADAM symptoms. Design and Methods. Prospective study including 40 patients recruited after a sildenafil therapeutic trial. Total testosterone and sex hormone binding globulin (SHBG) were measured to calculate the free androgen index. Prostate specific antigen (PSA) was measured and repeated 2 months after treatment. A rating score was used for PADAM symptoms, and the 5-point abbreviated version of the International Index of Erectile Function (IIEF-5) to assess erectile function. Men failing to respond to sildenafil were randomized into two groups receiving sildenafil plus continuous TRT (group 1ST), and TRT (group IT) alone. Men partially responding to sildenafil were randomized into two groups receiving sildenafil plus continuous TRT for 2 months (group 2ST), or sildenafil alone (group 2S). Treatment efficacy was assessed by analysis of between-group differences. Results. Groups IT, 2S, and 2ST showed significant improvement in PADAM scores (P < 0.05, Wilcoxon matched pairs test). Patients receiving both sildenafil plus continuous TRT (groups IST and 2ST) showed significant improvement in IIEF-5 scores (P < 0.5, paired t-test). No significant changes in serum levels of PSA were detected (paired t-test). Conclusions. We conclude that TRT appears to be beneficial and safe in facilitating the erectile response and patient satisfaction with sildenafil in men with PADAM symptoms. Androgen supplementation should be carried out cautiously with careful monitoring to avoid possible adverse effects.
引用
收藏
页码:559 / 564
页数:6
相关论文
共 25 条
[1]   Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction [J].
Aversa, A ;
Isidori, AM ;
Spera, G ;
Lenzi, A ;
Fabbri, A .
CLINICAL ENDOCRINOLOGY, 2003, 58 (05) :632-638
[2]   Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction [J].
Aversa, A ;
Isidori, AM ;
De Martino, MU ;
Caprio, M ;
Fabbrini, E ;
Rocchietti-March, M ;
Frajese, G ;
Fabbri, A .
CLINICAL ENDOCRINOLOGY, 2000, 53 (04) :517-522
[3]   Issues in testosterone replacement in older men [J].
Bhasin, S ;
Bagatell, CJ ;
Bremner, WJ ;
Plymate, SR ;
Tenover, JL ;
Korenman, SG ;
Nieschlag, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3435-3448
[4]   Andropause: Hormone replacement therapy in the ageing male [J].
Comhaire, FH .
EUROPEAN UROLOGY, 2000, 38 (06) :655-662
[5]   IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF UROLOGY, 1994, 151 (01) :54-61
[6]  
FERRINI RL, 1998, AM J EPIDEMIOL, V15, P570
[7]  
GHANEM H, 2001, P 3 INT C ANDR MONTR, P739
[8]   Endocrine aspects of ageing in the male [J].
Gooren, LJG .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 145 (1-2) :153-159
[9]  
GOOREN LJG, 1994, J ANDROL, V15, P212
[10]  
Guay AT, 2001, J ANDROL, V22, P793